Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 8.57$. Average daily volumn in 3 months 9.82M. Market cap 8.82B



Stock symbol : TEVA. Exchange : NYSE. Currency : USD
Lastest price : 7.74$. Total volume : 19.35M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Teva Pharmaceutical Industries Limited (TEVA)
Last Price
7.74$
Change
0.07
Volume
19.35M

Previous Close7.67
Open7.77
Day Range7.68-7.81
Bid7.76 x 45.1k
Ask7.78 x 29.2k
Volume19.35M
Average Volume9.82M
Market Cap8.82B
Beta1.18
52 Week Range7.23-10.50
Trailing P/EN/A
Foward P/E2.99
Dividend (Yield %)N/A
Ex-Dividend Date2017-11-27



Financial Details


According to Teva Pharmaceutical Industries Limited's financial reports the company's revenue in 2021 were 15.88B an decrease(-6.25%) over the years 2020 revenue that were of 16.66B. In 2021 the company's total earnings were 417M while total earnings in 2020 were -3.99B(-113.9%).


Loading ...



Organization

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells ac... tive pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Market Cap:
8.82B
Revenue:
15.88B
Total Assets:
47.67B
Total Cash:
2.17B



News about "Teva Pharmaceutical Industries Limited"

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Position Boosted by Fieldpoint Private Securities LLC

Source from : Defense World - 2 days ago

Fieldpoint Private Securities LLC raised its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA โ€“ Get Rating) by 100,000.0% during the 1st quarter, according to the company in its ...See details»


stocknewscom-upgrades-teva-pharmaceutical-industries-nyseteva-to-buy-image

StockNews.com Upgrades Teva Pharmaceutical Industries (NYSE:TEVA) to โ€œBuyโ€

Source from : Defense World - 8 days ago

StockNews.com upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA โ€“ Get Rating) from a hold rating to a buy rating in a report released on Friday. A number of other equities analysts have ...See details»


Teva Pharmaceutical Industries Limited (NYSE: TEVA): Is It A Blank Check?

Source from : stocksregister - 9 days ago

Teva Pharmaceutical Industries Limited (NYSE:TEVA) price on Thursday, June 16, fall -4.31% below its previous dayโ€™s close as a downside momentum from buyers pushed the stockโ€™s value to $7.78. A look ...See details»


Teva Pharmaceutical Industries Limited (TEVA.VI)

Source from : Yahoo Finance - 17 days ago

Inc., U.S. affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), have reached an agreement with Aurobindo to resolve the dispute over Aurobindoโ€™s Abbreviated New Drug ...See details»


July 29th Options Now Available For Teva Pharmaceutical Industries (TEVA)

Source from : Nasdaq - 16 days ago

Investors in Teva Pharmaceutical Industries Ltd (Symbol: TEVA) saw new options become available today, for the July 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up ...See details»


Teva Pharmaceutical Industries Ltd BRDR - Stock Price vs Fair Value T1EV34

Source from : Morningstar%2c Inc. - 13 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...See details»


Teva- Pharmaceutical Industries Ltd. - ADR

Source from : U.S. News & World Report - 20 days ago

3D printing stocks are down a lot, which could make them a good value play for long-term investors.See details»


UBS Group Begins Coverage on Teva Pharmaceutical Industries (NYSE:TEVA)

Source from : ETF Daily News - 12 days ago

Arrowstreet Capital Limited Partnership increased its holdings in Teva Pharmaceutical Industries by 953.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,028,487 shares of ...See details»


Teva Pharmaceutical Industries Ltd ADR - Stock Sustainability TEV

Source from : Morningstar%2c Inc. - 11 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


waiting-for-the-fed-to-change-analysts-upgrade-or-downgrade-best-buy-oracle-teva-pharma-and-more-image

Waiting for the Fed to Change: Analysts Upgrade or Downgrade Best Buy, Oracle, Teva Pharma and More

Source from : 24/7 Wall St - 11 days ago

However, the drop may not be over, as more Fed rate hikes are on the way, and it is debatable as to whether these hikes are priced in. 24/7 Wall St. is reviewing additional analyst calls seen on ...See details»


Teva To Settle Austedo Patent Dispute With Aurobindo

Source from : Business Insider - 16 days ago

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) said that it has reached an agreement with Aurobindo to resolve the dispute over Aurobindo's Abbreviated New Drug Application or "ANDA" for a ...See details»


Teva Announces Settlement with Aurobindo Resolving AUSTEDOยฎ (deutetrabenazine) Patent Dispute

Source from : Stockhouse - 16 days ago

Teva Branded Pharmaceutical Products R&D, Inc. and Auspex Pharmaceuticals, Inc., U.S. affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), have reached an agreement with Aurobindo ...See details»


Analysts Anticipate 27% Gains Ahead For The Holdings of PPH

Source from : Nasdaq - 5 days ago

L ooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month fo ...See details»


Teva settles patent dispute with Aurobindo Pharma

Source from : moneycontrol.com - 16 days ago

US affiliates of Israel-based Teva Pharmaceutical Industries Ltd on June 9 announced that they have reached an agreement with India's Aurobindo Pharma to resolve a legal patent infringement ...See details»